Cargando…
Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease
BACKGROUND: The LipiDiDiet trial showed that Souvenaid, a medical food, might delay progression to dementia in prodromal Alzheimer’s disease (AD). The objective of this study was to assess the cost-utility of Souvenaid compared to placebo in patients with prodromal AD under the conditions applied in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731786/ https://www.ncbi.nlm.nih.gov/pubmed/33308302 http://dx.doi.org/10.1186/s13195-020-00737-9 |